Cyltezo
adalimumab-adbm · KIT · Boehringer Ingelheim Pharmaceuticals, Inc.
Cyltezo is a prescription medication that contains adalimumab-adbm, a biologic drug used to treat inflammatory conditions such as rheumatoid arthritis, psoriasis, and Crohn's disease. It comes as a kit for injection and works by reducing inflammation in the body.
Key Facts
- Brand Name
- Cyltezo
- Generic Name
- adalimumab-adbm
- NDC Code (Product)
0597-0375- Manufacturer
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Dosage Form
- KIT
- Marketing Status
- Application #
- BLA761058
- Marketing Start
- 07/01/2023
Recall History
No Recall HistoryFrequently Asked Questions
What is Cyltezo used for?
Cyltezo is a prescription medication that contains adalimumab-adbm, a biologic drug used to treat inflammatory conditions such as rheumatoid arthritis, psoriasis, and Crohn's disease. It comes as a kit for injection and works by reducing inflammation in the body.
Is Cyltezo a controlled substance?
Cyltezo is not classified as a controlled substance by the DEA.
What is the generic name for Cyltezo?
The generic name for Cyltezo is adalimumab-adbm. There are 9 other brand versions of adalimumab-adbm.
What is the NDC code for Cyltezo ?
The NDC (National Drug Code) for Cyltezo is 0597-0375, listed by Boehringer Ingelheim Pharmaceuticals, Inc..